These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 7756170)

  • 1. Inhibition of epidermal growth factor-stimulated EGF receptor tyrosine kinase activity in A431 human epidermoid carcinoma cells by polyamines.
    Faaland CA; Laskin JD; Thomas TJ
    Cell Growth Differ; 1995 Feb; 6(2):115-21. PubMed ID: 7756170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tyrosine kinase inhibitors. 14. Structure-activity relationships for methylamino-substituted derivatives of 4-[(3-bromophenyl)amino]-6-(methylamino)-pyrido[3,4-d]pyrimidine (PD 158780), a potent and specific inhibitor of the tyrosine kinase activity of receptors for the EGF family of growth factors.
    Rewcastle GW; Murray DK; Elliott WL; Fry DW; Howard CT; Nelson JM; Roberts BJ; Vincent PW; Showalter HD; Winters RT; Denny WA
    J Med Chem; 1998 Feb; 41(5):742-51. PubMed ID: 9513602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of cytotoxic effect of epidermal growth factor (EGF) on EGF receptor overexpressing cells is associated with attenuation of EGF receptor tyrosine kinase activity.
    Gardner DP; Shimizu N
    J Cell Physiol; 1994 Feb; 158(2):245-55. PubMed ID: 8106561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations in EGF-dependent proliferative and phosphorylation events in squamous cell carcinoma cell lines by a tyrosine kinase inhibitor.
    Brunton VG; Carlin S; Workman P
    Anticancer Drug Des; 1994 Aug; 9(4):311-29. PubMed ID: 7916899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidermal growth factor: modulator of murine embryonic palate mesenchymal cell proliferation, polyamine biosynthesis, and polyamine transport.
    Gawel-Thompson KJ; Greene RM
    J Cell Physiol; 1989 Aug; 140(2):359-70. PubMed ID: 2501317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of protein phosphorylations in variant A431 cells with different growth responses to epidermal growth factor.
    Buss JE; Chouvet C; Gill GN
    J Cell Physiol; 1984 Jun; 119(3):296-306. PubMed ID: 6202705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of epidermal growth factor receptor tyrosine kinase activity in A431 human epidermoid cells following psoralen/ultraviolet light treatment.
    Mermelstein FH; Abidi TF; Laskin JD
    Mol Pharmacol; 1989 Dec; 36(6):848-55. PubMed ID: 2557535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EGF stimulates polyamine uptake in Caco-2 cells.
    Milovic V; Deubner C; Zeuzem S; Piiper A; Caspary WF; Stein J
    Biochem Biophys Res Commun; 1995 Jan; 206(3):962-8. PubMed ID: 7832811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of platelet-derived growth factor and epidermal growth factor receptor signaling events after treatment of cells with specific synthetic inhibitors of tyrosine kinase phosphorylation.
    Lipson KE; Pang L; Huber LJ; Chen H; Tsai JM; Hirth P; Gazit A; Levitzki A; McMahon G
    J Pharmacol Exp Ther; 1998 May; 285(2):844-52. PubMed ID: 9580635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor necrosis factor regulates tyrosine phosphorylation on epidermal growth factor receptors in A431 carcinoma cells: evidence for a distinct mechanism.
    Donato NJ; Rosenblum MG; Steck PA
    Cell Growth Differ; 1992 May; 3(5):259-68. PubMed ID: 1378752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytoskeletal and morphological changes associated with the specific suppression of the epidermal growth factor receptor tyrosine kinase activity in A431 human epidermoid carcinoma.
    Nelson JM; Fry DW
    Exp Cell Res; 1997 Jun; 233(2):383-90. PubMed ID: 9194500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tyrosine kinase inhibitors. 13. Structure-activity relationships for soluble 7-substituted 4-[(3-bromophenyl)amino]pyrido[4,3-d]pyrimidines designed as inhibitors of the tyrosine kinase activity of the epidermal growth factor receptor.
    Thompson AM; Murray DK; Elliott WL; Fry DW; Nelson JA; Showalter HD; Roberts BJ; Vincent PW; Denny WA
    J Med Chem; 1997 Nov; 40(24):3915-25. PubMed ID: 9397172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of epidermal growth factor-stimulated protein kinase in control of proliferation of A431 cells.
    Gill GN; Buss JE; Lazar CS; Lifshitz A; Cooper JA
    J Cell Biochem; 1982; 19(3):249-57. PubMed ID: 6296169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PD153035, a tyrosine kinase inhibitor, prevents epidermal growth factor receptor activation and inhibits growth of cancer cells in a receptor number-dependent manner.
    Bos M; Mendelsohn J; Kim YM; Albanell J; Fry DW; Baselga J
    Clin Cancer Res; 1997 Nov; 3(11):2099-106. PubMed ID: 9815602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blockade of the epidermal growth factor receptor tyrosine kinase activity by quercetin and luteolin leads to growth inhibition and apoptosis of pancreatic tumor cells.
    Lee LT; Huang YT; Hwang JJ; Lee PP; Ke FC; Nair MP; Kanadaswam C; Lee MT
    Anticancer Res; 2002; 22(3):1615-27. PubMed ID: 12168845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth hormone attenuation of epidermal growth factor-induced mitogenesis.
    Wiepz GJ; Houtman JC; Cha D; Bertics PJ
    J Cell Physiol; 1997 Oct; 173(1):44-53. PubMed ID: 9326448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of the epidermal growth factor receptor associated with cytoskeletons of A431 cells.
    Roy LM; Gittinger CK; Landreth GE
    J Cell Physiol; 1989 Aug; 140(2):295-304. PubMed ID: 2745564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of tumor necrosis factor-alpha on the phosphorylation of tyrosine kinase receptors is associated with dynamic alterations in specific protein-tyrosine phosphatases.
    Ahmad F; Goldstein BJ
    J Cell Biochem; 1997 Jan; 64(1):117-27. PubMed ID: 9015760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of hepatocyte epidermal growth factor receptor mediated activation of mitogen-activated protein kinase signaling pathways in response to growth inhibition by a novel K vitamin.
    Wang Z; Wang M; Carr BI
    J Cell Physiol; 2000 Jun; 183(3):338-46. PubMed ID: 10797308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blockade of epidermal growth factor receptor function by bivalent and monovalent fragments of 225 anti-epidermal growth factor receptor monoclonal antibodies.
    Fan Z; Masui H; Altas I; Mendelsohn J
    Cancer Res; 1993 Sep; 53(18):4322-8. PubMed ID: 8364927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.